Sector consensus Shionogi & Co., Ltd.

Equities

Delayed Japan Exchange Other stock markets 22:30:00 2026-03-08 EDT			5-day change	1st Jan Change
3,358.00 ^JPY	-2.69%		-5.49%	+18.20%

03-04	Nxera Pharma Co., Ltd. Submits Marketing Authorization Application For Daridorexant In South Korea	CI
03-04	Nxera Submits South Korea Filing for Insomnia Drug Daridorexant	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
SHIONOGI & CO., LTD.	JP¥3,218	-6.75%	10
ELI LILLY AND COMPANY	US$1,214.34	+22.62%	29
JOHNSON & JOHNSON	US$235.25	-2.14%	24
ABBVIE INC.	US$248.86	+8.15%	29
ROCHE HOLDING AG	CHF 360.74	+5.73%	19
NOVARTIS AG	CHF 151.21	-4.52%	21
ASTRAZENECA PLC	GBX 219.64	+13.12%	21
MERCK & CO., INC.	US$127.22	+9.87%	27
AMGEN INC.	US$350.04	-5.28%	28
GILEAD SCIENCES, INC.	US$156.59	+8.8%	27
NOVO NORDISK A/S	DKK 330.95	+33.5%	21
PFIZER INC.	US$28.43	+5.09%	26
BRISTOL-MYERS SQUIBB COMPANY	US$62.16	+3.1%	25
VERTEX PHARMACEUTICALS INCORPORATED	US$535.56	+17.27%	27
GSK PLC	GBX 20.32	-0.28%	20
SANOFI	€98.49	+28.93%	23
CHUGAI PHARMACEUTICAL CO., LTD.	JP¥9,823.33	+2.48%	15
TAKEDA PHARMACEUTICAL COMPANY LIMITED	JP¥5,536.87	-2.64%	15
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	CN¥82.39	+48.28%	17
HALEON PLC	GBX 4.266	+13.15%	16
Average	1,140.23	+9.92%	22
Weighted average by Cap.	702.45	+9.93%	25